Skip to main content

Featured

RMB stock trading backed

Secretary for Financial Services & the Treasury Christopher Hui today expressed his gratitude to various listed issuers in Hong Kong for their support to the proposal of setting up a renminbi (RMB) stock trading counter.   Mr Hui stated that further to the help rendered by the Legislative Council Panel on Financial Affairs regarding the Government's proposed measures to promote the issuance and trading of RMB stocks in Hong Kong and enhance the trading mechanism, a number of listed issuers have also backed the proposal.   Such listed issuers will actively explore the feasibility of setting up a new RMB trading counter for their issued shares.   Mr Hui explained that listed issuers who indicated their support today include Hang Seng Index constituent stocks with promising turnover.   “Their participation is a vote of confidence to the development of RMB securities in Hong Kong, which will be conducive to our promotion work to other issuers, enabling Hong Kong to graduall

Testing unaffected by virus mutation

Secretary for Food & Health Prof Sophia Chan today said the reagent used by the Public Health Laboratory Services Branch for COVID-19 testing is not affected by the genetic transformation of the virus’ S protein.   She told legislators the laboratory services branch under the Centre for Health Protection is currently using the polymerase chain reaction (PCR) nucleic acid test to conduct and process COVID-19 testing.   On vaccine procurement, Prof Chan said the vaccines advance purchased by the Government are the inactivated virus vaccine by Sinovac Biotech (Hong Kong), the nucleic acid vaccine by Fosun Pharma/German drug developer BioNTech, and the viral vector vaccine by AstraZeneca/University of Oxford.   The health chief noted the Government’s goal is to procure at least one vaccine from each vaccine technology platform. This means it will purchase four different vaccines, with the aggregate number of doses sufficient to serve at least two times the city’s population.   This is to diversify risks and ensure sufficient supplies of safe and efficacious vaccines for the whole of Hong Kong, Prof Chan added.
http://dlvr.it/RrS93B

Popular Posts